C22.3 Angiosarcoma of liver

Name of the Condition

• Angiosarcoma of liver

Summary

Angiosarcoma of the liver is a rare type of primary liver cancer that originates in the blood vessel lining cells (endothelial cells) of the liver. It is an aggressive malignancy that can impair liver function and may spread rapidly to other organs or tissues if not treated promptly. The condition is distinct from other liver cancers due to its vascular origin and rapid progression.

Causes

The development of angiosarcoma involves genetic mutations in liver endothelial cells that lead to uncontrolled cell growth. Contributing factors may include chronic liver disease, environmental exposures (e.g., vinyl chloride, thorium dioxide), and genetic predispositions. These mutations disrupt normal cellular regulation, allowing cancerous cells to proliferate.

Risk Factors

• Chronic liver disease (e.g., cirrhosis)
• Exposure to vinyl chloride or thorium dioxide
• Thorotrast (radiocontrast agent) exposure
• Arsenic exposure
• Age, particularly over 60
• Male gender
• Prior radiation therapy to the abdomen
• Genetic conditions (e.g., hereditary hemorrhagic telangiectasia)

Symptoms

• Unexplained weight loss
• Abdominal pain or swelling
• Jaundice (yellowing of skin/eyes)
• Fatigue
• Nausea or vomiting
• Loss of appetite
• Rapidly enlarging liver (hepatomegaly)
• Bruising or bleeding easily

Diagnosis

Diagnosis begins with a physical examination and assessment of symptoms. Imaging tests (e.g., CT, MRI, ultrasound) are used to detect liver abnormalities. A biopsy of liver tissue is typically performed to confirm malignancy, and blood tests (e.g., liver function tests) may be ordered to evaluate liver health. Additional tests (e.g., angiography) may assess vascular involvement.

Treatment Options

Treatment depends on the stage and extent of the disease. Surgical resection may be considered for localized tumors. Chemotherapy or radiation therapy may be used to manage advanced or unresectable cases. Targeted therapies or clinical trials may be options for some patients. Palliative care focuses on symptom management and quality of life.

Prognosis and Follow-Up

Prognosis is generally poor due to the aggressive nature of the disease and late diagnosis. Survival rates vary based on tumor size, spread, and treatment response. Regular follow-up with imaging and blood tests is recommended to monitor for recurrence or progression. Supportive care is often integrated into treatment plans.

Complications

• Liver failure
• Metastasis to other organs (e.g., lungs, bones)
• Severe bleeding from tumor rupture
• Ascites (fluid buildup in the abdomen)
• Malnutrition
• Infection due to impaired liver function

Lifestyle & Prevention

• Avoid exposure to known carcinogens (e.g., vinyl chloride)
• Limit alcohol consumption to reduce liver stress
• Maintain a healthy weight to lower liver disease risk
• Manage chronic liver conditions (e.g., hepatitis, cirrhosis) with medical care
• Discuss occupational exposures with a healthcare provider

When to Seek Professional Help

Seek immediate medical attention for persistent abdominal pain, unexplained weight loss, jaundice, or signs of liver failure (e.g., confusion, bruising). Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Code C22.3 is specific to angiosarcoma of the liver. Documentation should specify the anatomical site (liver) and histological type (angiosarcoma) to support accurate coding. Ensure differentiation from other liver malignancies (e.g., hepatocellular carcinoma) and confirm no additional codes are required for metastatic sites unless explicitly documented.